Work

Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells

Year: 2013

Type: article

Source: Cell Death and Differentiation

DOI: 10.1038/cdd.2013.136

Authors: M Venere, P Hamerlik, Q Wu, R D Rasmussen, L A Song, A Vasanji, N Tenley, W A Flavahan, A B Hjelmeland, J Bartek, J N Rich

Institutions: Cleveland Clinic, Institute of Molecular and Translational Medicine, Danish Cancer Society, Palacký University Olomouc, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: James S. McDonnell Foundation, European Commission, National Research Foundation, Danmarks Grundforskningsfond, Lundbeckfonden, Novo Nordisk, Danmarks Frie Forskningsfond, Novo Nordisk Fonden, National Institutes of Health, National Cancer Institute

Awards: G1040845586, G2073124653, G2407259800, G2752773248, G2798916649, G6086735254, G6975561687, G826790257, G9000060645, G9000335273

OpenAlex ID: W2039881995

FWCI: 7.905

Cites: 55

Cited by: 172

Related to: 10